ascendis pharma glp-1 receptor agonist weight management diabetes treatments Top Agonists Balance Loss Efficacy, Safety Schematic illustration of monoagonists, dual
Description
Yamamoto, H

Implementation requires systematic comparison of available options and adherence to established safety protocols

Clinical implication The potential ocular complications associated with GLP-1 RAs need careful clinical consideration

Elucidating the underlying cellular and molecular mechanisms could potentially usher in the development of new generations of incretin mimetics with enhanced efficacy and fewer adverse effects

Longer-term coverage of GLP-1s remains uncertain The program is scheduled to sunset after Dec
